In this webinar, you’ll learn:

The common enterprise challenges in managing incidental findings — from undefined ownership to fragmented communication

Where operational bottlenecks show up in current tracking models, and why patients slip through

What makes an AI-enabled longitudinal care model scalable across every patient entry point

Meet the speakers

Tiffany Dean, RT, BS

Program Director, Healthy Person Program, Lifepoint Health

Tiffany Dean, RT, BS, is a seasoned health care leader and mammography professional with 24 years of experience dedicated to advancing breast imaging. She currently serves as the director of the Healthy Person Program at Lifepoint, where she spearheads the systemwide Healthy Breast Program. In this executive role, Dean drives the standardization of breast imaging practices across all Lifepoint facilities, strengthens high-risk program development, and champions comprehensive dense breast screening strategies. Dedicated to elevating care quality and expanding access, her work focuses on improving clinical consistency, increasing early detection and ensuring every patient receives a unified, proactive and supportive breast health experience.

LouAnn Bala, RN, MSN

Vice President, Clinical Operations, Eon

LouAnn Bala, RN, MSN, is a senior nurse executive and digital health leader with more than 25 years of experience advancing health care innovation, clinical quality and operational transformation across complex care environments. At Eon, she leads care management and clinical transformation initiatives that integrate AI, automation and data-driven workflows to improve patient outcomes, while increasing operational efficiency at scale. Bala has been published in the Journal of Nursing Administration and is a frequent speaker on the intersection of health care technology, quality improvement and the future of AI-enabled care delivery.

Ready to get started?

Bring this level of early detection to your
health system

SMH grew incidental lung findings routed to its nodule clinic 100x and now detects
lung cancer at more than twice the national early-stage rate. Talk to our team about
building the same kind of program.

Contact Us